Skip to content
S

Sahil Kumar

Publications (2)

Navigating the Complexities of SGLT-2 Inhibitor Therapy: Balancing Benefits and Risks for Type 2 Diabetes Management

Mahadev Khurana & Sahil Kumar · Asian Journal of Research and Reports in Endocrinology · 2024

Sodium-glucose co-transporter 2 (SGLT-2) inhibitors have emerged as potent oral hypoglycemic drugs for managing type 2 diabetes, offering significant benefits such as improved cardiovascular and renal functions along with weight loss. However, their usage is accompanied by variou...

Open access Research Article